Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsOxidative stress and free radicals in COPD--implications and relevance for treatmentReactive oxygen species-activated nanomaterials as theranostic agentsNeu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammationSulforaphane protects the heart from doxorubicin-induced toxicityAdjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary diseaseEicosapentaenoic acid attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signalingCOPD: balancing oxidants and antioxidants.Bursopentin (BP5) protects dendritic cells from lipopolysaccharide-induced oxidative stress for immunosuppression.Associations between antioxidants and all-cause mortality among US adults with obstructive lung function.Dietary vitamin C intake protects against COPD: the Korea National Health and Nutrition Examination Survey in 2012.Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease.The cell membrane is the main target of resveratrol as shown by interdisciplinary biomolecular/cellular and biophysical approaches.Cadmium-induced toxicity is rescued by curcumin: A review.Flavonoid Fraction of Orange and Bergamot Juices Protect Human Lung Epithelial Cells from Hydrogen Peroxide-Induced Oxidative Stress.The pathophysiological role of mitochondrial oxidative stress in lung diseases.Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells.Sulfated caffeic acid dehydropolymer attenuates elastase and cigarette smoke extract-induced emphysema in rats: sustained activity and a need of pulmonary delivery.Long-term exposure to ultrasonically nebulized distilled water and saline causes cellular influx and oxidative stress in lung tissue of rats.Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial.Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease, asthma-COPD overlap syndrome and bronchial asthma.A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
P2860
Q26766294-F2EB35FF-5D11-4F26-BA80-E65C6E297E04Q26830076-A0C79EB2-AAA6-4380-9196-F9751C8061BBQ26865564-70C2DC64-CEFA-40D3-996E-1170F1A557C4Q28386473-4646B9DF-5379-458E-84F2-0C4E6E85A6F8Q28387218-B7A6E195-2318-450F-88F5-C439F772E8E0Q33895428-89EFDA72-E462-4AC2-9F09-5A63F731EAE4Q34511130-B03A315E-DAB8-4E95-A1A9-4D25578A49CEQ35063488-50128E8A-3783-4D30-A73B-D3F187E88820Q35557207-74D0CB81-8C50-426F-B2D0-EB8958792D73Q36028338-3407FC92-87FE-43DC-A43B-3AAE96E6A542Q37397831-EC3584F9-F00D-4A42-AC99-638A4E116059Q38156225-E2B50CB4-0374-4BDB-A321-13F64DB03B92Q39069294-73984889-CE2A-4607-AB2D-98D8D1C7D0B5Q39441766-A023E9F3-F223-45D7-8D83-96C4F1D3B717Q40683657-3894DCF6-3A3D-4468-B79A-49DE7CDDAF0EQ42377386-6A5AA005-959C-4272-9BD9-5A16CFBD36DAQ42538234-052A98E2-B7AB-430A-A79A-C85DB650EE21Q44998183-267D6561-BBF5-454E-B8F1-F013A8CB0FBFQ46626098-7D37DC2C-4153-42C4-BBF2-243CE42A1918Q47777342-691DF487-C4CA-47FC-8C95-295C6171AE49Q51565263-0A492D76-1E4A-4EC8-A108-057A0B1F74A9Q53203837-1DAB4C94-5A90-44F3-B32B-B32D4AD7E6D4
P2860
Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacological and dietary an ...... obstructive pulmonary disease.
@ast
Pharmacological and dietary an ...... obstructive pulmonary disease.
@en
Pharmacological and dietary an ...... obstructive pulmonary disease.
@nl
type
label
Pharmacological and dietary an ...... obstructive pulmonary disease.
@ast
Pharmacological and dietary an ...... obstructive pulmonary disease.
@en
Pharmacological and dietary an ...... obstructive pulmonary disease.
@nl
prefLabel
Pharmacological and dietary an ...... obstructive pulmonary disease.
@ast
Pharmacological and dietary an ...... obstructive pulmonary disease.
@en
Pharmacological and dietary an ...... obstructive pulmonary disease.
@nl
P2093
P1476
Pharmacological and dietary an ...... obstructive pulmonary disease.
@en
P2093
P304
P356
10.2174/0929867311320120004
P577
2013-01-01T00:00:00Z